Hypertension Trial, Recruiting NCT06538454 Sponsor: University of Sao Paulo Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06538454
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between the ages of 50 and 65 years old
  • Women who have been through menopause, meaning their periods have stopped for 12 months or more
  • Women who have already been diagnosed with high blood pressure and are currently taking medication to treat it
  • Women who are not currently physically active

Who may not be able to join:

  • People with a history of other heart or blood vessel problems, such as heart failure, heart attack, or stroke
  • People with a higher level of obesity, specifically a body mass index (BMI) of 35 or above (confirm with trial site if unsure how to calculate this)
  • People taking certain blood pressure or heart medications known as beta-blockers and/or non-dihydropyridine calcium channel blockers (check with the trial site if there is uncertainty about which medication category applies)
  • People whose resting blood pressure readings are above a certain level — specifically, top number above 160 or bottom number above 105
  • People who are unable to do resistance or strength-based exercise due to joint, muscle, or memory and thinking-related reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 16981806105

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 July 2024
Est. completion
1 September 2024

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Values of systolic and diastolic blood pressure (mmHg)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov